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Purpose: To formulate bioadhesive clotrimazole vaginal tablets using natural polymers in order to 
provide long-term therapeutic action at the site of infection.  
Methods: The tablets were prepared by direct compression using bioadhesive polymer mixtures: 
hydroxypropyl methylcellulose/sodium carboxymethylcellulose (HPMC/NaCMC) and HPMC/Guar gum 
(GG) in different ratios. Differential scanning calorimetry (DSC) and Fourier transform infrared (FT-IR) 
spectroscopic evaluations were carried out to assess compatibility between the drug and the excipients. 
The tablets were subjected to various pre- and post-compression evaluations, including in vitro drug 
release, in vitro bioadhesive strength, swelling and stability studies.  
Results: The results show that all the formulations satisfied Indian Pharmacopoeial specifications for 
tablet parameters. DSC and FT-IR data indicate there was no interaction between the drug and the 
excipients. Drug dissolution rate at pH 6.0 followed the rank order: HPMC)/NaCMC > HPMC/GG. There 
was increase in swelling index with time at 37 
0
C. The combination of HPMC with NaCMC showed 
greater mucoadhesive strength and superior controlled drug release to the formulations prepared with 
GG polymer mixture. Furthermore, the release properties of the former in pH 6.0 buffer, as well as 
release mechanism (n values), were negligibly affected by ageing.  
Conclusion: This study indicates the possible use of suitable mixtures of natural and semi-synthetic 
cellulosic polymers for the preparation of clotrimazole mucoadhesive tablets for application as a vaginal 
controlled delivery system.  
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INTRODUCTION 
 
Conventional vaginal drug delivery systems 
(e.g., pessaries, foams, creams, gels and 
tablets) have some limitations such as 
leakage, messiness and low residence time, 
which contribute to poor subject or patient 
compliance [1]. Vaginal tablets appear to be 
useful dosage forms as they are easy to use, 
portable and the required quantity of the drug 
can be readily administered [2,3]. 
Approximately 75 % of women have vaginal 
infection with a Candida strain during their life 
time; about 40 to 50 % of them suffer a 
second one, and a small percentage show a 
chronic course [4,5].  
 
Clotrimazole is known to be very effective 
locally and presents no major side effects [6]. 
Hydrophilic polymers that bind to mucin or 
epithelial surfaces increase the residence 
time of the dosage form at the action or 
absorption site, and thus could be useful in 
solving bioavailability problems resulting from 
a too short stay of the pharmaceutical dosage 
form at the absorption site [7].  
 
This study addresses the possible use of a 
mixture of HPMC in different ratios with 
NaCMC or GG for the preparation of 
mucoadhesive tablets of clotrimazole, a 
widely used antifungal agent for vaginal 






Clotrimazole was received free of charge 
from Zyg Pharma Mumbai, India while 
sodium caboxymethylcellulose (NaCMC), 
hydroxypropylmethylcellulose (HPMC) and 
Guar Gum (GG) (all from Loba Chemie, 
Mumbai, India) were used as the polymers. 
All other chemicals were of analytical grade. 
 
Preparation of clotrimazole vaginal tablets  
 
Tablets containing 20 % clotrimazole and 
weighing 500 mg were prepared by direct 
compression of the formulation in a 10-station 
tablet machine (minipress-1674, Rimek, 
India) fitted with round, flat-faced 12 mm 
punches. Table 1 shows the composition of 
the formulations. A particle size of less than 
160 µm for all components was selected to 
avoid any fractional segregation and the 
formulation well mixed with a mortar and 
pestle to obtain a homogenous blend prior to 
compression 
 




Approx. weight of each tablet = 500mg 
 
Evaluation of some tablet parameters 
 
Six tablets, randomly taken from each batch, 
were evaluated for hardness using a digital 
hardness tester (Inweka - iHT100, India). 
Friability studies were carried out as per USP 
XXVIII [8]. Twenty tablets were weighed and 
placed in the Roche friabilator apparatus. It 
was rotated at 25 rpm for 4 min, after which 
the tablets were dedusted and weighed 
again. Percent loss in weight was taken as 
friability. The weight variation test was carried 
out as per Indian Pharmacopoeia [9]. Twenty 
tablets were randomly selected from each 
batch and individually weighed. The mean 
weight and the percent deviation of each 
tablet were calculated. For drug content 
determination, three tablets, randomly taken 
from each batch, were powdered and an 
amount equivalent to 100 mg of clotrimazole 
was dissolved in 100 mM acetate buffer (pH 
6.0) overnight using a magnetic stirrer. After 
filtration, the solution was assayed 
Formulation Ingredient 
(mg) 
F1 F2 F3 F4 F5 F6 
Clotrimazole  100 100 100 100 100 100 
HPMC  200 200 200 200 200 200 
Sodium 
CMC  
100 125 150 -- -- -- 
Guar gum  -- -- -- 100 125 150 
Magnesium 
stearate  
10 10 10 10 10 10 
Di-calcium 
phosphate  
90 65 40 90 65 40 
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spectrophotometrically (Shimadzu-1601, 
Japan) for clotrimazole at 261 nm using 100 




Fourier transform infrared spectroscopy 
(FTIR) 
 
The spectra were recorded for pure drug, 
polymer and tablet using Fourier transform 
infrared spectroscopy (FTIR, Shimadzu 8400 
S, Japan). Samples were prepared in KBr 







Differential scanning calorimetry (DSC) was 
used to assess the compatibility of 
clotrimazole - excipient as well as excipient–
excipient compatibility [10]. DSC scans of the 
drug and excipients were performed, 
separately and in a mixed state using a 
Dupont 9900 thermal analyzer with a 910 
DSC module. The calorimetric measurements 
were made with an empty cell (high purity 
alpha alumina discs of Dupont Company) as 
the reference. The scans were taken under 
nitrogen atmosphere over a temperature 
range of 25 to 330 °C and at a scan rate of 
20.0 °C/min.  
 
Swelling studies  
 
The swelling index for the tablets was 
determined in 100 mM acetate buffer (pH 6) 
at 37 ± 0.1 °C. The weight of the tablets was 
determined and each tablet was placed 
separately in a 25-mL beaker containing 10 
mL buffer. The beakers were stored at 37 ± 
0.1 °C. The tablets were removed at different 
time intervals (1, 2, 3, 4, 6, 8, 10 and 12 h) 
and weighed at each of these intervals after 
removing the surface water using a blotting 
paper. Swelling index was calculated as in Eq 
2. 
 
Swelling index (%) = (W2–W1)/ W1 x 100..… (2)  
 
Where where W1 is the original weight of the 
tablet before commencement of the test and 
W2 is the tablet weight at each swelling 
interval. 
     
Bioadhesion studies 
 
The modified balance method [11] was 
adopted to measure bioadhesion properties.  
Isolated sheep vaginal tissue was fixed to 
steel piece with cyanoacrylate adhesive. This 
was kept in a beaker and then acetate buffer 
(pH 6), pre-warmed to 37° C, was added to 
the beaker to cover the upper surface of the 
mucosa in order to maintain its viability. The 
tablet was attached to the upper clamp with 
adhesive and then the beaker was slowly 
raised until the substrate came in contact with 
the tablet. A preload of 50 g was placed on 
the clamp for 5 min (preload time) so that 
adhesion can be established. After this, the 
preload was removed and water was added 
to the beaker at a constant rate of 100 
drops/min. The addition of water was stopped 
when the bioadhesive system was detached 
from the mucosa. The weight required to 
detach the system from the mucosa was 
noted. The experiment was repeated 6 times 
with fresh mucosa in an identical manner.  
 
Drug release studies  
 
Drug release studies were performed using 
USP XXIV dissolution apparatus type II, as 
previously described [12], rotating at 25 rpm 
and 37 ± 0.1 °C in 500 mL of 100 mM acetate 
buffer (pH 6) over a 12 h period. The test 
tablet (500 mg) was glued to the centre of a 9 
cm diameter glass disc. Five ml of the sample 
solution was withdrawn at predetermined 
time intervals.  An equal amount of fresh 
dissolution medium was used to replenish the 
dissolution medium immediately after the 
withdrawal of the test sample. The samples 
were analysed spectrophotometrically at 261 
nm.  
 
Evaluation of release kinetics 
 
In order to understand the mechanism and 
kinetics of drug release, the results of the in 
vitro  drug  release  study were  fitted to Eq 3,  
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Table 2:  Physicochemical characteristics (mean ± SD) of the bioadhesive tablets 
 
Parameter 





















F1 499±7 3.3±0.2 4.6±0.8 0.2 98.3±0.2 119±1 
F2 504±6 3.3±0.1 5.4±0.3 0.2 98.9±0.4 125±1 
F3 500±6 3.3±0.2 5.5±0.7 0.2 99.2±0.8 132±1 
F4 499±8 3.3±0.1 4.8±1.0 0.3 98.6±0.8 67±1 
F5 499±7 3.3±0.2 4.6±0.9 0.2 99.3±0.7 72±1 
F6 496±5 3.3±0.1 5.4±0.3 0.2 98.4±0.6 82±1 
    
   a
 n = 20; 
b




from which the release exponent “n” was 
calculated [13].                               
 
Mt/M∞ = 1- A (exp -Kt)  ………………….. (3) 
        
where Mt/M∞ is the fraction of drug released 
at time t, k is the kinetic constant of the 
system, and n is the diffusional release 





The stability of the formulated tablets was 
assessed by packing them in aluminum foil, 
sealed tightly and stored for 90 days at 30 ± 2 
o
C and 65 ± 5 % RH or at 40 ± 2 
o
C and 75 ± 
5 % RH.  The tablets were analysed for drug 
content and drug release on days 15, 45 and 
90. 
 
Statistical data analysis 
 
Statistical data analysis was performed using 
Student t-test at 95 % level of confidence with 







The physicochemical properties of the tablets 
are summarized in Table 2. Mean tablet 
weight for all the batches was in the range of 
496 - 504 mg. Thus, they all complied with 
the mean weight variation requirement of the 
Indian Pharmacopoeia [9] as no batch varied 
by more than 5 % from the tablet weight. This 
indicates consistency in tablet formulation 
and production. 
 
Mean hardness of the tablets (4.6 – 5.5 kg) 
indicates satisfactory tablet strength 
especially as friability was also less than 1 %, 
which complied with the requirements of USP 
28 [8]. Mean drug content was 98.8 ± 0.6 % 





Tablet swelling data for tablet formulations F1 
to F6 at 37 °C in pH 6 acetate buffer are 
shown in Figure 2. Swelling after 1 h for the 
bioadhesive tablets varied between 80 and 
112%. Formulations made with 
HPMC/NaCMC showed a comparatively 
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higher initial swelling than formulations made 
with HPMC/guar gum. Swelling of the tablets 
after 10 h varied between 164 and 180 % but 




Figure 2: Swelling of tablet formulations F1 
(♦), F2 (□), F3 (▲), F4 (◊), F5 (∗) and F6 (ο). 
in pH 6 acetate buffer at 37 °C  
Bioadhesion 
The results of the bioadhesion studies are 
listed in Table 2.The tablets prepared with 
HPMC and GG (batches F4 and F5) showed 
lower bioadhesive strength than those made 
with the combination of HPMC and NaCMC 
(batches F1 - F3). The force required to 
detach tablets containing NaCMC from sheep 
vaginal tissue was 1.77, 1.74 and 1.60 - fold 
greater than that for tablets containing 
equivalent amounts of GG.  
 
FT IR and DSC 
 
The IR spectra and DSC thermograms of 
pure clotrimazole and tablet formulations F2 
and F5 are shown in Figure 1. The peak at 
3450 cm
-1
 indicate -NH stretching, 2961 cm
-1
 
for the C-H stretching, 1564 cm
-1
 for the 
aromatic N-O stretching, and 1266 cm
-1
 for 
the C-O stretching. These are the major 
peaks of the spectra of the drug. All these 
peaks were present in the spectra of 
formulations F2 and F5 and thus this 
confirms the presence of the free drug in the 
tablet and that the drug did not interact with 
the excipients.  
 
 
Fig 1: FTIR spectra and DSC thermograms of 
pure clotrimazole and tablet formulation  
 
DSC studies of the pure drug and tablet 
formulations were carried out to determine if 
there was any interaction between the drug 
and the other tablet components. The 
thermogram of pure clotrimazole shows a 
sharp endothermic peak at 146 °C, which 
corresponds to its melting point. Formulations 
F2 and F5 also showed endothermic peaks at 
144 and 145 °C, respectively, due to the 
presence of clotrimazole. Thus, the thermal 
data did not reveal any interaction between 




Fig 3: Effect of polymer type and ratio on the 
release of clotrimazole from bioadhesive vaginal 
tablets. Key: F1 (◊), F2 (•), F3 (∆), F4 (), F5 (∗) 




Fig. 3 shows the drug release profiles of the 
tablet formulations (F1 to F6). It was 
observed from the data obtained that after 12 
h, the release of drug was in the rank order, 
F1 (71.9 %) > F2 (64.5 %) > F3 (55.8 %) > F4 
(51.2 %) > F5 (46.2 %) > F6 (42.1 %). Thus, 
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drug release from formulations made with 
HPMC/GG was slower that from 
HPMC/NaCMC polymer blends. Drug release 
was markedly delayed in the tablet 





The value found for n, the release exponent 
in the Korsemeyer-Peppas equation, was 
between 0.638 and 0.884 in all cases, thus 
indicating a non-Fickian release behavior 
controlled by a combination of diffusion and 
chain relaxation mechanism.   
 
Stability of the tablet formulations 
 
No statistically significant changes (p > 0.05) 
in drug content and release of the 
formulations occurred over the period of the 
stability study. Thus, the additives used did 
not adversely affect the stability of the drug; 





HPMC, NaCMC and GG were chosen as 
bioadhesive polymers for this study because 
of their good swelling characteristics and 
have been reported to form a gel layer 
around drug coreand this interaction of 
HPMC with NaCMC and GG results in the 
formation of a gel on the surface of the tablet 
which aids in minimizing the burst effect of 
HPMC-based systems [14,15]. NaCMC - 
HPMC interaction facilitates rapid formation 
of a viscous gel layer upon hydration and this 
has been regarded as an essential first step 
in achieving controlled drug release from 
matrix tablets [16].  
 
All the tablets showed considerable swelling 
properties in pH 6 medium due to the 
presence of hydrophilic polymers in the 
formulations. The swelling characteristics of a 
polymer contributes to its bioadhesive 
behaviour. To manifest maximum adhesive 
strength, an optimum water concentration is 
needed for polymer particles [17]. Polymeric 
matrices start to swell and build a gel layer 
around the tablet core when they come in 
contact with the medium and this feature 
governs drug release.  HPMC, NaCMC and 
GG were mot only swellable polymers but 
also showed good mucoadhesive property.  
As shown in Figure 2, at the initial stage, 
there was an initial rapid rise in swelling index 
due to the entry of water via metastable 
pores in the polymer matrix of the tablets. 
This mechanism, known as swelling 
hysteresis, was followed by swelling caused 
by diffusion processes [18].   
 
It has been reported that the presence of 
drug affects the property of a polymer matrix 
[19]. Clotrimazole is slightly soluble at pH 6.0, 
and since it replaced part of the hydrophilic 
polymer matrix of the tablet, the wettability of 
the tablet surface and hence water 
penetration within the tablet matrix would be 
reduced. Formulations containing NaCMC 
showed less swelling, due probably to the 
formation of a protective gel layer of the 
polymer prior to entry of water into the matrix 
and hydration of the inner layers. As NaCMC 
becomes hydrated and forms a swollen gel, 
dissolution and surface erosion of this water-
logged gel occur simultaneously. The 
swelling plateau reached thereafter may be 
due to the solvent front on each face of the 
matrix meeting in the core of the tablet, 
leaving no additional unhydrated polymer to 
hydrate and expand [20]. It has also been 
reported that hydrogen bond interaction 
between NaCMC and HPMC hinders the 
swelling of CMC [21]. Swelling reached a 
peak in all the formulations after the 10
th
 h as 
polymer erosion ensued. 
 
It has been suggested by several workers 
that the initial interaction between a polymer 
and a biological surface is through 
electrostatic interaction followed by 
mechanical interlocking of the polymer chains 
[21]. Increasing polymer concentration 
caused an increase in the mucoadhesive 
strength. Hydration of a mucoadhesive 
polymer is essential to initiate the 
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mucoadhesive bonding process. Mucoad-
hesive property was promoted by higher 
mucoadhesive strength due to the optimum 
concentration of HPMC in the formulations. 
The combination of HPMC and NaCMC 
showed greater mucoadhesive strength than 
HPMC/GG. HPMC a is long-chain, non-ionic 
polymer and its mucoadhesive property may 
be due to the formation of physical or 
hydrogen bond with mucus components of 
the tissue used. The tablets with higher 
polymer content showed greater 
mucoadhesive strength. 
  
There was no initial burst effect in all the 
formulations. This may be due to the rapid 
hydration and gelation of the polymers in the 
tablets. The greater the content of the 
polymers in the formulations, the lower the 
release rate of the drug.  It has been reported 
that use of HPMC in a matrix tablet as the 
only polymer results in a very slow release of 
drug due the build–up of an excessively 
viscous gel which is very resistant to water 
penetration and erosion [16]. Since the 
amount of HPMC used in the tablet 
formulations was constant, the concentration 
of NaCMC and GG was a significant factor in 
the rate of drug release. As stated earlier, 
formulations prepared with HPMC/GG 
showed a highly viscous gel around the tablet 
as well as a higher swelling index.  Since the 
erosion rate of the swollen gel is slow 
compared with the rate of advance of the 
swelling front into the glassy tablet core, the 
diffusional path length for the drug would 
increase with time, thus causing the release 
rate to decrease. Release kinetic analysis 
showed that the “n” value in the Korsemyere-
Peppas equation was between 0.5 and 1.0, 
thus indicating anomalous transport or case II 
transport. Stability studies indicate that the 





Clotrimazole vaginal tablets formed with a 
mixture of NaCMC and HPMC at 
concentrations of 40 and 20 %, respectively, 
slowly released 72% of the drug over 12 h. 
Generally, the tablets exhibited good swelling 
and bioadhesiveness, thus promoting 
sustained effect in the vagina. These results 
also indicate that clotrimazole tablets 
prepared with a suitable HPMC/NaCMC 
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